Fast-track endovascular aortic repair: Interim report from the prospective LIFE registry

Objective To assess the feasibility, safety, and clinical utility of a fast‐track endovascular aneurysm repair (EVAR) protocol. Background Despite recent advances in EVAR technology and techniques, considerable opportunity exists to further improve EVAR efficiency and outcomes. Methods Eligible pati...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Catheterization and cardiovascular interventions 2016-12, Vol.88 (7), p.1118-1123
Hauptverfasser: Krajcer, Zvonimir, Ramaiah, Venkatesh G., Huetter, Meredith, Miller, Larry E.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Objective To assess the feasibility, safety, and clinical utility of a fast‐track endovascular aneurysm repair (EVAR) protocol. Background Despite recent advances in EVAR technology and techniques, considerable opportunity exists to further improve EVAR efficiency and outcomes. Methods Eligible patients underwent elective EVAR with the Ovation Prime stent graft. Successful completion of the fast‐track protocol required bilateral percutaneous access, avoidance of general anesthesia and intensive care unit admission, and next‐day discharge. Patients were followed through 1‐month post‐treatment. Results Between October 2014 and September 2015, 129 patients were enrolled in the study. Vascular access, stent graft delivery, and stent graft deployment were successful in all patients. The fast‐track EVAR protocol was successfully completed in 114 (88%) patients. Bilateral percutaneous access was achieved in 97% of cases. Comparing patients who completed fast‐track requirements to those who failed at least one component, procedure time was 86 vs. 122 min, use of general anesthesia was 0% vs. 20%, need for intensive care unit stay was 0% vs. 13%, hospital stay was 1.1 vs. 2.1 days, and postoperative groin pain severity (0–10 scale) was 1.2 vs. 4.0. No type I or III endoleaks, serious device‐related adverse events, AAA ruptures, surgical conversions, or AAA‐related secondary procedures were reported. One (0.9%) patient in the fast‐track group died from acute respiratory failure. Conclusions Initial results from the LIFE study are encouraging and suggest that a fast‐track protocol is feasible, safe, and may improve efficiency of healthcare resource allocation in select patients undergoing EVAR. © 2016 Wiley Periodicals, Inc.
ISSN:1522-1946
1522-726X
DOI:10.1002/ccd.26626